Long Hill Capital
China AI drug discovery platform StoneWise raises $100m
StoneWise, a Chinese biotech start-up that uses artificial intelligence (AI) technology to develop new drugs, has raised $100 million in Series B funding across two tranches.
Fund focus: Long Hill burns the midnight oil
Embarking on its first Zoom-based fundraise, China's Long Hill Capital succeeding in closing just above target on $300 million while significantly diversifying the LP base
Long Hill raises $300m for third China VC fund
Long Hill Capital closed its third US dollar-denominated fund at $300 million with a remit to pursue healthcare and longevity-related opportunities, which includes start-ups focused on wellness and services aimed at aging consumers.
Long Hill invests $30m in Chinese O2O pharmacy player
Chinese digital healthcare platform inCarey has raised $30 million in an extended tranche of Series B funding from Long Hill Capital.
PE-backed Hygeia completes $286m Hong Kong IPO
Chinese radiotherapy business Hygeia Healthcare, which counts Warburg Pincus, Boyu Capital, and CITIC Capital among its investors, raised HK$2.22 billion ($286.4 million) in its Hong Kong IPO.
China VCs get more selective - AVCJ Forum
Chinese venture capital firms are doubling down on areas in which they have domain expertise as the spectrum of opportunities widens, industry participants told the AVCJ Forum.
Chinese online art education business raises $40m
Chinese art education platform Yiqi Technology Group has raised $40 million in the first tranche of a Series C round led by Tencent Holdings. It is said to be the largest-ever funding round for a start-up in this space.
Venture capital: The battle to be different
VC fundraising has been on a roll in Asia as managers raise larger sums to address fast-growing investment opportunities. GPs must consider what – and how much – makes them stand out from the crowd
China tech IPOs: Battle of the bourses
China has rolled out another proposal for a start-up friendly listing regime in Shanghai, this time with presidential imprimatur. PE investors are skeptical as to how quickly it could challenge Hong Kong
Fund focus: LPs queue up for a piece of Long Hill
China’s Long Hill Capital scales up with its latest VC fund with strong support from new and existing LPs. Sector specialization has helped underpin much of the progress
Long Hill closes second China VC fund at $265m
China-focused Long Hill Capital has reached a final close of $265 million on its second US dollar-denominated VC fund as well as a first close of about $30 million for its first renminbi vehicle.
Long Hill raises $252m for China VC fund, has yet to close
Long Hill Capital, a Chinese venture capital firm that spun out from New Enterprise Associates (NEA) in 2016, has raised $252.2 million for its second VC fund.
Traditional Chinese medicine: Innovating antiquity
As the time-honored but largely unprofessional industry of traditional Chinese medicine reinvents itself for the 21st century, private equity could play a role in a massive healthcare overhaul
China’s Bianlifeng acquires VC-backed Lingwa
Bianlifeng, a Chinese PE-backed cashier-free convenience store operator, has acquired a controlling stake in its peer Lingwa. Financial terms were not disclosed.
New opportunities breed new VCs in Asia – AVCJ Forum
A byproduct of Asia’s technology boom is the emergence of a new generation of GPs that have spun out from global venture capital players and internet companies, with a view to capturing opportunities presented by this fast-moving sector.
China VC: Early birds
With concerns that China's venture capital boom is heading for a bust, investors are increasingly targeting early-stage strategies. Renminbi funds are also coming more into the reckoning
Fund focus: Long Hill aspires to specialization
With the support of his former employer, New Enterprise Associates, Xiaodong Jiang has gone independent with Long Hill Capital. Early-stage healthcare and consumer services are now in his sights